Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

Daiichi Sankyo chooses Veeva Vault to streamline submissions, eTMF, and quality management Daiichi Sankyo has selected Veeva Systems' Veeva Vault eTMF, Veeva Vault QualityDocs, and Veeva Vault Submissions to unify content management throughout its research and development (R&D) operations worldwide.
Automation > IT & Software > News
Eleven Biotherapeutics completes exclusive licensing deal for IL-6 antagonist antibody technology Eleven Biotherapeutics, a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, announced the effectiveness of the exclusive licensing deal with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. (Roche).
Automation > IT & Software > News Genmab signs commercial license deal with Gilead for DuoBody technology Genmab has entered an agreement to grant Gilead Sciences an exclusive license and an option on a second exclusive license, to use the DuoBody technology platform to create and develop bispecific antibody candidates for a therapeutic program targeting HIV.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
Lantern Pharma signs deal to evaluate BioNumerik’s Tavocept
Lantern Pharma has entered into an exclusive agreement to evaluate BioNumerik Pharmaceuticals' Tavocept for human therapeutic indications using Lantern’s 5-M theranostic platform.
Automation > IT & Software > News
Pluristem Therapeutics adopts Medidata's cloud technology platform
Placenta-based cell therapy products developer Pluristem Therapeutics has adopted Medidata's cloud technology platform.
Automation > IT & Software > News
Ligand signs multi-program LTP technology licensing deal with Nucorion Pharmaceuticals
Ligand Pharmaceuticals has signed a license agreement for three programs utilizing Ligand’s LTP (Liver Targeting Prodrug) technology with Nucorion Pharmaceuticals, a venture-funded biotechnology company focused on developing anti-cancer and anti-viral agents initially directed to China.
Automation > IT & Software > News
Synaffix achieves improved therapeutic index compared to both FDA-approved ADCs
Synaffix has completed a new set of preclinical studies that further supports the potential for its technology to enable safer and more effective targeted cancer therapeutics.
Automation > IT & Software > News
PeptiDream licenses PDPS technology to Genentech
PeptiDream has entered into a Technology License Agreement with US-based Genentech, a member of the Roche Group, to non exclusively license its Peptide Discovery Platform System (PDPS) technology.
Automation > IT & Software > News
Hanmi Pharmaceutical expands technology partnership with Medidata
By PBR Staff Writer
South-Korea based Hanmi Pharmaceutical is expanding its technology partnership with Medidata, which provides cloud-based solutions for clinical research.
Automation > IT & Software > News
Pfizer selects Oracle Cloud for clinical data management and trial management
Pfizer has selected Oracle Cloud for clinical data management and trial management across its clinical trial portfolio.
Automation > IT & Software > News
Virtual reality smartphone app provides glimpse into life with dementia
An innovative virtual reality smartphone app – A Walk Through Dementia – will launch at a three-day public installation at St Pancras International Station from 2 June.
Automation > IT & Software > News
Kalytera Therapeutics licenses Transdermal drug delivery technology from Delivra
Delivra has entered into a technology licensing agreement with Kalytera Therapeutics.
Automation > IT & Software > News
Integral Molecular develops B-Cell cloning technology to discover rare antibodies against membrane proteins
Integral Molecular has developed an ultra high-throughput microfluidic B-cell cloning technology that can interrogate tens of millions of immune cells (B-cells), enabling deep mining of entire immune repertoires to discover rare and diverse monoclonal antibodies for therapeutic purposes.
Automation > IT & Software > News
View all IT & Software news or find news targeted to your interests